-+ 0.00%
-+ 0.00%
-+ 0.00%

Dyadic Presents C1 Platform Data Showing Vaccine Antigen Production in About 15 Days

PUBT·11/17/2026 12:53:02
Listen to the news
Dyadic Presents C1 Platform Data Showing Vaccine Antigen Production in About 15 Days
  • Dyadic International presented C1 platform data showing purified Bundibugyo Ebola antigens produced in approximately 15 days from plasmid receipt.
  • C1-produced antigens achieved CHO-comparable yield and purity; structural analysis supported a native-like trimer conformation for MT1001.
  • The platform requires no mammalian viral clearance, potentially simplifying manufacturing and reducing costs.
  • DYAI-100 established clinical manufacturing precedent under cGMP; its Phase 1 trial met the primary safety endpoint at both dose levels.
  • Antibody production reached approximately 12-13 grams per liter in seven days using human-like G2/G1 glycans.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dyadic International Inc. published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.